165 related articles for article (PubMed ID: 6687638)
1. [Chemotherapy of Hodgkin disease with modified MOPP].
Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
[No Abstract] [Full Text] [Related]
2. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
3. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
4. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
[No Abstract] [Full Text] [Related]
5. [Combined therapy of lymphogranulomatosis].
Vorob'ev AI; Fokina NT; Brilliant MD; Fil'kova EM
Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):3-7. PubMed ID: 6895412
[No Abstract] [Full Text] [Related]
6. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
7. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
[No Abstract] [Full Text] [Related]
9. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
10. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
Berényi E; Szegedi G
Orv Hetil; 1984 Nov; 125(45):2737-40, 2743. PubMed ID: 6548560
[No Abstract] [Full Text] [Related]
11. [The practice of chemotherapy with the DeVita protocol].
Gassmann W; Schmitz N; Löffler H
Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488
[No Abstract] [Full Text] [Related]
12. [Treatment of lymphogranulomatosis].
Baĭsogolov GD
Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Borromeo VD; Wilner FR; Axelrod AR; Schneider JR
Mich Med; 1975 Sep; 74(27):557-63. PubMed ID: 1160622
[No Abstract] [Full Text] [Related]
14. [10 years of DeVita protocol].
Gassmann W; Schmitz N; Löffler H
Dtsch Med Wochenschr; 1982 Jul; 107(27):1043-4. PubMed ID: 6896303
[No Abstract] [Full Text] [Related]
15. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
16. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K
Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884
[TBL] [Abstract][Full Text] [Related]
17. [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Kolygin BA; Kharatishvili ZV
Vopr Onkol; 1983; 29(8):12-5. PubMed ID: 6688487
[TBL] [Abstract][Full Text] [Related]
18. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
19. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
20. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
